| Autor: |
Dellino M; Department of Biomedical Sciences and Human Oncology, University of Bari, 70121 Bari, Italy.; Clinic of Obstetrics and Gynecology, 'San Paolo' Hospital, 70121 Bari, Italy., Cascardi E; Department of Medical Sciences, University of Turin, 10124 Turin, Italy.; Pathology Unit, FPO-IRCCS Candiolo Cancer Institute, Str. Provinciale 142 km 3.95, 10060 Candiolo, Italy., Tomasone V; Department of Biomedical Sciences and Human Oncology, University of Bari, 70121 Bari, Italy., Zaccaro R; Clinic of Obstetrics and Gynecology, 'San Paolo' Hospital, 70121 Bari, Italy., Maggipinto K; Clinic of Obstetrics and Gynecology, 'San Paolo' Hospital, 70121 Bari, Italy., Giacomino ME; Department of Biomedical Sciences and Human Oncology, University of Bari, 70121 Bari, Italy., De Nicolò M; Department of Biomedical Sciences and Human Oncology, University of Bari, 70121 Bari, Italy., De Summa S; Bioinformatician-Molecular Diagnostics and Pharmacogenetics Unit, IRCCS-Istituto Tumori 'Giovanni Paolo II', 70124 Bari, Italy., Cazzato G; Department of Emergency and Organ Transplantation, University of Bari 'Aldo Moro', 70121 Bari, Italy., Scacco S; Department of Basic Medical Sciences and Neurosciences, University of Bari 'Aldo Moro', 70121 Bari, Italy., Malvasi A; Department of Biomedical Sciences and Human Oncology, University of Bari, 70121 Bari, Italy., Pinto V; Department of Biomedical Sciences and Human Oncology, University of Bari, 70121 Bari, Italy., Cicinelli E; Department of Biomedical Sciences and Human Oncology, University of Bari, 70121 Bari, Italy., Carriero C; Department of Biomedical Sciences and Human Oncology, University of Bari, 70121 Bari, Italy., Di Vagno G; Clinic of Obstetrics and Gynecology, 'San Paolo' Hospital, 70121 Bari, Italy., Cormio G; Gynecologic Oncology Unit, IRCCS Istituto Tumori Giovanni Paolo II, Department of Interdisciplinary Medicine (DIM), University of Bari 'Aldo Moro', 70121 Bari, Italy., Genco CA; Departmental of Cervical-Carcinoma Screening, ASL Bari, 70121 Bari, Italy. |
| Abstrakt: |
Human papilloma virus (HPV) infection could be considered a social disease, both for its high incidence, especially in younger subjects, and for the risk of neoplastic evolution linked to viral infection. Therefore, the National Health System, in collaboration with the state, must help women to understand the oncological risk of HPV and suitable methods of prevention. We conducted an Italian monocentric survey on HPV risk information as part of cervical cancer screening. An anonymous questionnaire was administered to 200 women with high-risk positive HPV and low-grade cervical lesions during second-level cervical cancer screening at the Gynecology and Obstetrics Unit of the "San Paolo" Hospital. From this survey, the need to improve communication for patients has emerged, as currently it is not exhaustive. In response to this need, organizational changes have been implemented to centralize the moment of counseling in the second levels of screening and to improve the training of health workers in level I as well as family doctors. In addition, psychological support was also proposed to patients who requested it, as was the dissemination of material such as that produced by GISCI (Italian Cervico-Carcinoma Screening Group) and updated in May 2018, which provides 100 answers to questions on HPV in order to achieve effective and comprehensive communication. This investigation requires further development, and the expansion of this investigation to the multicenter level is already underway. Therefore, this survey will represent a cornerstone for further discussion on the topic considering the necessity of appropriate communication in the oncological context. |
